QS Pharma gets nod from EMA for commercial manufacture

By Melissa Fassbender

- Last updated on GMT

QS Pharma specializes in formulation development and manufacturing of small molecule drug products. (Image: iStock/BernardaSv)
QS Pharma specializes in formulation development and manufacturing of small molecule drug products. (Image: iStock/BernardaSv)

Related tags Medicine

The European Medicines Agency (EMA) has approved QS Pharma to manufacture medicinal products for commercial use in Europe.

At the request of the EMA, the Dutch Health Care Inspectorate (IGZ) inspected QS Pharma’s Boothwyn, PA-based manufacturing facility in February 2017.

The contract development and manufacturing organization (CDMO), previously a Charles River Laboratories business, was acquired by Quotient Clinical​ the same month for approximately $75m in cash.

According to the company, the inspection focused on two NDA filed products and the company’s overall quality systems.

QS Pharma is now approved to manufacture medicinal products for the US, Europe, and Japan.

Related news

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Related suppliers